Top Stories

Glaxo to invest in German vaccine maker CureVac


The logo of the biopharmaceutical company CureVac is seen in front of the company’s headquarters in Tuebingen, southern Germany on June 23, 2020.

thomas kienzle/Agence France-Presse/Getty Images

GlaxoSmithKline on Monday said it was taking a stake in German vaccines maker CureVac, the latest move by a major drugmaker to boost capabilities to fight pandemics.

Glaxo said CureVac’s mRNA technology would complement its own capabilities.

Under the terms of the deal, GlaxoSmithKline


will make an equity investment in…


DBS CEO says ‘a big, big challenge’ is looming in the global economy

Previous article

China’s Ant Financial to go public in dual Shanghai-Hong Kong listing

Next article

You may also like

Leave a Reply

Notify of

More in Top Stories